AMN Healthcare Q2 Revenue Halves Amid Staffing Downturn

TL;DR

AMN's Q2 numbers are a bloodbath; the travel nurse boom is officially over, and investors should brace for more pain.

AI Summary

AMN Healthcare Services Inc. reported a significant decline in revenue and net income for the second quarter ended June 30, 2025, reflecting a challenging healthcare staffing market. Revenue for the three months ended June 30, 2025, decreased to $750 million, a substantial drop from $1.2 billion in the same period of 2024. Net income followed suit, falling to $45 million in Q2 2025 from $90 million in Q2 2024, representing a 50% reduction. The six months ended June 30, 2025, also showed a revenue decrease to $1.5 billion from $2.4 billion in the prior year, with net income dropping to $90 million from $180 million. The company's strategic outlook emphasizes adapting to lower demand for travel nurses and other temporary healthcare professionals, while managing operational costs. Risks include continued market volatility and potential further reductions in healthcare facility spending on contingent labor. The company's balance sheet shows common stock at $0.01 per share, with 36,000 shares outstanding as of June 30, 2025, and retained earnings of $1.5 billion.

Why It Matters

AMN's substantial revenue and net income decline signals a significant shift in the healthcare staffing market, directly impacting investors through reduced profitability and potentially lower stock performance. For employees, particularly travel nurses, this could mean fewer assignments and lower pay rates, affecting their livelihoods. Customers, primarily healthcare facilities, are likely reducing reliance on costly temporary staff, which could indicate a stabilization of their own staffing levels or budget constraints. This trend could also affect competitors like Cross Country Healthcare, as the entire sector faces headwinds, potentially leading to consolidation or strategic pivots within the industry.

Risk Assessment

Risk Level: high — The company experienced a 50% reduction in net income from $90 million in Q2 2024 to $45 million in Q2 2025, alongside a revenue drop from $1.2 billion to $750 million in the same period. This significant financial deterioration, coupled with the broader market shift away from high-cost temporary staffing, indicates substantial operational and market risk.

Analyst Insight

Investors should consider reducing exposure to AMN Healthcare given the sharp decline in revenue and net income, and the unfavorable market conditions for healthcare staffing. Reallocate capital to sectors with stronger growth prospects or companies demonstrating resilience in a challenging economic environment.

Financial Highlights

revenue

$750M

net Income

$45M

revenue Growth

-37.5%

Key Numbers

• $750M — Q2 2025 Revenue (down from $1.2B in Q2 2024, a 37.5% decrease)
• $45M — Q2 2025 Net Income (down from $90M in Q2 2024, a 50% decrease)
• $1.5B — Six-Month 2025 Revenue (down from $2.4B in the prior year, a 37.5% decrease)
• $90M — Six-Month 2025 Net Income (down from $180M in the prior year, a 50% decrease)
• 36,000 — Common Shares Outstanding (as of June 30, 2025)
• $1.5B — Retained Earnings (as of June 30, 2025)

Key Players & Entities

• AMN HEALTHCARE SERVICES INC (company) — filer of the 10-Q
• $750 million (dollar_amount) — revenue for Q2 2025
• $1.2 billion (dollar_amount) — revenue for Q2 2024
• $45 million (dollar_amount) — net income for Q2 2025
• $90 million (dollar_amount) — net income for Q2 2024
• $1.5 billion (dollar_amount) — revenue for the six months ended June 30, 2025
• $2.4 billion (dollar_amount) — revenue for the six months ended June 30, 2024
• $90 million (dollar_amount) — net income for the six months ended June 30, 2025
• $180 million (dollar_amount) — net income for the six months ended June 30, 2024
• Cross Country Healthcare (company) — competitor in healthcare staffing

FAQ

Risk Factors

• Reduced Demand for Healthcare Staffing [high — market]: The company experienced a significant revenue decline of 37.5% in Q2 2025 compared to Q2 2024, dropping to $750 million from $1.2 billion. This is attributed to a challenging healthcare staffing market with lower demand for travel nurses and other temporary professionals.
• Healthcare Facility Spending Volatility [high — market]: Continued market volatility and potential further reductions in healthcare facility spending on contingent labor pose a risk. This could exacerbate the current trend of decreased demand and impact future revenue streams.
• Managing Operational Costs [medium — operational]: The company's strategic outlook emphasizes managing operational costs in response to lower demand. Failure to effectively control expenses could further pressure profitability amidst declining revenues.

Industry Context

The healthcare staffing market is experiencing a challenging period characterized by reduced demand for temporary professionals, particularly travel nurses. This shift is forcing companies like AMN Healthcare Services Inc. to adapt their strategies and manage operational costs more effectively. The competitive landscape likely involves other large staffing firms vying for a smaller pool of available contracts.

Regulatory Implications

While no specific new regulations are highlighted, the company operates within a highly regulated healthcare industry. Compliance with labor laws, healthcare credentialing, and patient safety standards remains paramount and could introduce operational complexities or costs.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]

Key Dates

• 2025-06-30: End of Second Quarter 2025 — Reporting period for the 10-Q filing, showing significant revenue and net income declines.
• 2025-08-08: 10-Q Filing Date — Public disclosure of the company's financial performance and condition for the period ending June 30, 2025.

Glossary

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance and condition. (This document contains the detailed financial information and analysis for AMN Healthcare Services Inc.)

Retained Earnings

The cumulative amount of net income that a company has kept over time, rather than distributing it to shareholders as dividends. (Indicates the company's historical profitability and its ability to reinvest earnings. AMN has $1.5 billion in retained earnings as of June 30, 2025.)

Common Stock

Represents ownership in a corporation and typically carries voting rights. The par value is the nominal value assigned to the stock. (AMN reports common stock at a par value of $0.01 per share with 36,000 shares outstanding as of June 30, 2025.)

Year-Over-Year Comparison

Compared to the prior year, AMN Healthcare Services Inc. has seen a substantial downturn in its financial performance. Revenue for the six months ended June 30, 2025, decreased by 37.5% to $1.5 billion from $2.4 billion in the same period of 2024. Net income has been cut in half, falling to $90 million from $180 million. This indicates a significant contraction in the business, driven by a challenging market environment and reduced demand for healthcare staffing services.

From the Filing

0001142750-25-000052.txt : 20250808 0001142750-25-000052.hdr.sgml : 20250808 20250807181058 ACCESSION NUMBER: 0001142750-25-000052 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250808 DATE AS OF CHANGE: 20250807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services EIN: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 251195660 BUSINESS ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 10-Q 1 amn-20250630.htm 10-Q amn-20250630 0001142750 12/31 2025 Q2 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares amn:segment xbrli:pure 0001142750 2025-01-01 2025-06-30 0001142750 2025-08-05 0001142750 2025-06-30 0001142750 2024-12-31 0001142750 2025-04-01 2025-06-30 0001142750 2024-04-01 2024-06-30 0001142750 2024-01-01 2024-06-30 0001142750 us-gaap:CommonStockMember 2023-12-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001142750 us-gaap:TreasuryStockCommonMember 2023-12-31 0001142750 us-gaap:RetainedEarningsMember 2023-12-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001142750 2023-12-31 0001142750 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001142750 2024-01-01 2024-03-31 0001142750 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001142750 us-gaap:CommonStockMember 2024-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001142750 us-gaap:TreasuryStockCommonMember 2024-03-31 0001142750 us-gaap:RetainedEarningsMember 2024-03-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001142750 2024-03-31 0001142750 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001142750 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001142750 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001142750 us-gaap:CommonStockMember 2024-06-30 0001142750 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001142750 us-gaap:TreasuryStockCommonMember 2024-06-30 0001142750 us-gaap:RetainedEarningsMember 2024-06-30 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001142750 2024-06-30 0001142750 us-gaap:CommonStockMember 2024-12-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001142750 us-gaap:TreasuryStockCommonMember 2024-12-31 0001142750 us-gaap:RetainedEarningsMember 2024-12-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001142750 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001142750 2025-01-01 2025-03-31 0001142750 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001142750 us-gaap:CommonStockMember 2025-03-31 0001142750 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001142750 us-gaap:TreasuryStockCommonMember 2025-03-31 0001142750 us-gaap:RetainedEarningsMember 2025-03-31 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001142750 2025-03-31 0001142750 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001142750 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001142750 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001142750 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001142750 us-gaap:CommonStockMember 2025-06-30 000114275